Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-AFP for Re-treatment of Perianal Fistulas
NCT03209700Phase 1Completed
- Start
- Jul 2017
- Primary completion
- Dec 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Autologous mesenchymal stromal cell coated fistula plug in perianal fistula. Primary endpoint: Treatment-related adverse events at 12 months. Started Jul 2017; status: completed.
02
Drugs
Autologous mesenchymal stromal cell coated fistula plug
03
Conditions
perianal fistula
Beyond the preview
Go deeper on NCT03209700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03209700.